This slide contains in-dept knowledge about prescribing in geriatric patients. Steps how to overcome polypharmacy and how to increase medication adherence in geriatrics. It also tells about geriatrics care. Examples of case studies are also included.
Patient medication adherence, Medication adherence, Causes of medication non-adherence, Problems linked with Medication Non-adherence, Factors affecting medication adherence, Patient related factors, Social and Economic factor, Disease related factor, Health care provider related factors, Therapy related factors, pharmacist role in the medication adherence, role of pharmacist in the medication adherence, monitoring of patient medication adherence, Direct method, Indirect method
For proper use of medication rational drug use (RDU) is raised. Requirements of rational drug use and it's different steps and roles of pharmacists are described here.
Etiopathogenesis and pharmacotherapy of DIPDs
a. the pathophysiology of selected disease states and the rationale for drug therapy;
b. the therapeutic approach to management of these diseases;
c. the controversies in drug therapy;
d. the importance of preparation of individualised therapeutic plans based on diagnosis;
e. needs to identify the patient-specific parameters relevant in initiating drug therapy,
and monitoring therapy (including alternatives, time-course of clinical and laboratory
indices of therapeutic response and adverse effects);
f. describe the pathophysiology of selected disease states and explain the rationale for
drug therapy;
g. summarise the therapeutic approach to management of these diseases including
reference to the latest available evidence;
h. discuss the controversies in drug therapy;
i. discuss the preparation of individualised therapeutic plans based on diagnosis; and
j. identify the patient-specific parameters relevant in initiating drug therapy, and
monitoring therapy (including alternatives, time-course of clinical and laboratory
indices of therapeutic response and adverse effects).
Introduction to daily activities of clinical pharmacist.
Drug therapy monitoring,
Medication chart review
Clinical Progress
Pharmacist intervention
Detection and management of ADRs
Critical evaluation of biomedical literature - clinical pharmacyShaistaSumayya
Reviewing the ‘Biomedical Literature’ poses a great challenge to the clinical professionals.
Evaluating a scientific article is a complex task.
Knowledge of the standard anatomy of an article and idiosyncrasy of various types of studies will assist the reader to review the ‘Biomedical Literature’ efficiently
Biomedical Literature includes critical appraisal of the following contents:
Title
Abstract
Introduction
Objective
Materials and Methods
Study Designs
Bias
Statistics
Results and Analysis
Discussion and Conclusion
References
Patient medication adherence, Medication adherence, Causes of medication non-adherence, Problems linked with Medication Non-adherence, Factors affecting medication adherence, Patient related factors, Social and Economic factor, Disease related factor, Health care provider related factors, Therapy related factors, pharmacist role in the medication adherence, role of pharmacist in the medication adherence, monitoring of patient medication adherence, Direct method, Indirect method
For proper use of medication rational drug use (RDU) is raised. Requirements of rational drug use and it's different steps and roles of pharmacists are described here.
Etiopathogenesis and pharmacotherapy of DIPDs
a. the pathophysiology of selected disease states and the rationale for drug therapy;
b. the therapeutic approach to management of these diseases;
c. the controversies in drug therapy;
d. the importance of preparation of individualised therapeutic plans based on diagnosis;
e. needs to identify the patient-specific parameters relevant in initiating drug therapy,
and monitoring therapy (including alternatives, time-course of clinical and laboratory
indices of therapeutic response and adverse effects);
f. describe the pathophysiology of selected disease states and explain the rationale for
drug therapy;
g. summarise the therapeutic approach to management of these diseases including
reference to the latest available evidence;
h. discuss the controversies in drug therapy;
i. discuss the preparation of individualised therapeutic plans based on diagnosis; and
j. identify the patient-specific parameters relevant in initiating drug therapy, and
monitoring therapy (including alternatives, time-course of clinical and laboratory
indices of therapeutic response and adverse effects).
Introduction to daily activities of clinical pharmacist.
Drug therapy monitoring,
Medication chart review
Clinical Progress
Pharmacist intervention
Detection and management of ADRs
Critical evaluation of biomedical literature - clinical pharmacyShaistaSumayya
Reviewing the ‘Biomedical Literature’ poses a great challenge to the clinical professionals.
Evaluating a scientific article is a complex task.
Knowledge of the standard anatomy of an article and idiosyncrasy of various types of studies will assist the reader to review the ‘Biomedical Literature’ efficiently
Biomedical Literature includes critical appraisal of the following contents:
Title
Abstract
Introduction
Objective
Materials and Methods
Study Designs
Bias
Statistics
Results and Analysis
Discussion and Conclusion
References
Quality use of medicines in geriatric patients with their Physiological changes with aging, altered Pharmacokinetics and Pharmacodynamics with ADR's, Guidelines for prescribing the older people and the role of clinical pharmacist in geriatric prescribing.
GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...Abhinav S
Geriatric pharmacology is a specialized field focusing on medication use in elderly individuals
It explore challenges like polypharmacy, age-related changes in drug metabolism, and the importance of personalized treatment plans for older patients.
20% of hospitalization for those > 65 are due to the medication they’re taking
WHAT IS GERIATRICS. GERONTOLOGY, THEORIES OF AGING, Alteration of PHARMACODYNAMICS parameters IN GERIATRICS, Alteration of PHARMACOKINETICS parameters IN GERIATRICS,
Basic introduction to patient counselling for the clinical pharmacy services. Educating the patient on their disease, medication and lifestyle for better patient care and quicker recovery.
A complete drug profile of Tacrolimus an immunosuppressant used for organ transplant. It consist of PK/PD, MOA, Indication & Uses, Contraindications, Warnings & Precautions, Drug-interaction, Doses & Administration, Dosage forms, Chemical Formula, Side-Effects, Adverse Drug Reactions, Therapeutic Drug Monitoring (TDM).
Research Methodology In Medical Research. This presentation gives an comprehensive overview of research methodology in biomedical research also includes different types of medical research and ethics in medical research.
Role of PK PD in Antibiotic Stewardship Program with case study. This presentation gives an comprehensive overview about role of PK PD in antibiotic stewardship program.
This presentation describes about the cause, parthenogenesis, risk factors, clinical diagnosis, symptoms, complications and treatment of salpingitis (Hydrosalpinx). This presentation also consist a real case.
This is a real case of Breast Carcinoma. The presentation gives an overview of breast cancer topic with introduction, definition, causes, risk factors, genetic factor and treatment options.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Prescribing in Geriatrics
1.
2. Objectives
1. Understand key issues in geriatric
pharmacotherapy
2. Understand the effect age on
pharmacokinetics and
pharmacodynamics
3. Discuss risk factors for adverse drug
events and ways to mitigate them
4. Understand the principles of drug
prescribing for older patients
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
2
3. Challenges of Geriatric
Pharmacotherapy
New drugs available each year
FDA approved and off-label indications are expanding
Changing managed-care formularies
Advanced understanding of drug-drug interactions
Increasing popularity of “nutriceuticals”
Multiple co-morbid states
Polypharmacy
Medication compliance
Effects of aging physiology on drug therapy
Medication cost
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
3
4. Why is guideline required for Geriatric
Prescription?
➢ Elderly patients are at higher risk of adverse
events.
➢ ADRs are 2 to 3 times greater compared to
younger patients.
➢ Studies shows that 1/5 of all patients above 65
years experiences an ADR.
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
4
5. 30% of admissions due to drug related problems
2/3 of nursing facility residents have ADE over 4 years
106,000 deaths and $85 billion for medication related
problems in 2000
5th cause of death
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
5
6. Predictors of Adverse Drug Events
> 4 prescription medications
Length of stay in hospital > 14 days
> 4 active medical problems
Admission to general medical unit
History of alcohol use
Lower mean MMSE score
2-4 new medications added during
hospitalization
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
6
10. Geriatric Brain Function
Brain mass and cerebral blood flow
BBB may become more permeable
Secondary memory may be diminished
Short term memory difficulties 2° to decline in
Learning
Information retrieval
Processing speed
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
10
11. Pharmacokinetics (PK)
Absorption
bioavailability: the fraction of a drug dose reaching the systemic
circulation
Distribution
locations in the body a drug penetrates expressed as volume per
weight (e.g. L/kg)
Metabolism
drug conversion to alternate compounds which may be
pharmacologically active or inactive
Elimination
a drug’s final route(s) of exit from the body expressed in terms of half-
life or clearancePrescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
11
12. Effects of Aging on Absorption
Rate of absorption may be delayed
Lower peak concentration
Delayed time to peak concentration
Overall amount absorbed (bioavailability)
is unchanged
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
12
13. Hepatic First-Pass Metabolism
For drugs with extensive first-pass
metabolism, bioavailability may increase
because less drug is extracted by the liver
Decreased liver mass
Decreased liver blood flow
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
13
14. Factors Affecting Absorption
Route of administration
What it taken with the drug
Divalent cations (Ca, Mg, Fe)
Food, enteral feedings
Drugs that influence gastric pH
Drugs that promote or delay GI motility
Comorbid conditions
Increased GI pH
Decreased gastric emptying
DysphagiaPrescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
14
15. Effects of Aging on Volume of Distribution (Vd)
Aging Effect Vd Effect Examples
body water Vd for hydrophilic
drugs
ethanol, lithium
lean body mass Vd for for drugs
that bind to muscle
digoxin
fat stores Vd for lipophilic
drugs
diazepam, trazodone
plasma protein
(albumin)
% of unbound or
free drug (active)
diazepam, valproic acid,
phenytoin, warfarin
plasma protein
(1-acid glycoprotein)
% of unbound or
free drug (active)
quinidine, propranolol,
erythromycin, amitriptyline
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD 15
16. Aging Effects on Hepatic
Metabolism
Metabolic clearance of drugs by the liver may be
reduced due to:
decreased hepatic blood flow
decreased liver size and mass
Examples: morphine, meperidine, metoprolol,
propranolol, verapamil, amitryptyline, nortriptyline
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
16
17. Metabolic Pathways
Pathway Effect Examples
Phase I: oxidation,
hydroxylation,
dealkylation, reduction
Conversion to
metabolites of lesser,
equal, or greater
diazepam, quinidine,
piroxicam,
theophylline
Phase II:
glucuronidation,
conjugation, or
acetylation
Conversion to inactive
metabolites
lorazepam, oxazepam,
temazepam
** NOTE: Medications undergoing Phase II hepatic metabolism
are generally preferred in the elderly due to inactive metabolites
(no accumulation)
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD 17
18. High Extraction
Examples of high ER drugs with decreased
clearance:
Meperidine, morphine
Metoprolol, propranolol
Amitriptyline, nortriptyline
Verapamil
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
18
19. Other Factors Affecting Drug
Metabolism
Gender
Comorbid conditions
Smoking
Diet
Drug interactions
Race
Frailty
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
19
20. Concepts in Drug Elimination
Half-life
time for serum concentration of drug to decline by
50% (expressed in hours)
Clearance
volume of serum from which the drug is removed per
unit of time (mL/min or L/hr)
Reduced elimination drug accumulation and
toxicity
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
20
21. Effects of Aging on the Kidney-Renal
Elimination
Decreased kidney size
Decreased renal blood flow
Decreased number of functional nephrons
Decreased tubular secretion
Result: glomerular filtration rate (GFR)
Decreased drug clearance: atenolol,
gabapentin, H2 blockers, digoxin,
allopurinol, quinolones
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
21
23. Renally-Eliminated Active Metabolites
Meperidine (normeperidine)
Morphine (M3G and M6G)
Propoxyphene (norpropoxyphene)
Venlafaxine (O-desmethylvenlafaxine)
Carbamazepine (Carbamazepine-10,11-epoxide)
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
23
24. Estimating GFR in the Elderly
Creatinine clearance (CrCl) is used to
estimate glomerular rate
Serum creatinine alone not accurate in the
elderly
lean body mass lower creatinine production
glomerular filtration rate
Serum creatinine stays in normal range,
masking change in creatinine clearance
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
24
25. Drug Dosing and Measures of Renal
Function
Use creatinine clearance
Calculated or measured
Estimated CrCl (ml/min) = (140-age) x (IBW) * 0.85 for females
72 x SCr
If SCr < 1, use SCr = 1 to adjust for muscle mass
Serum creatinine (used alone)
An unreliable marker in elderly
**Formula for IBW(Ideal Body Weight)
For males: IBW=50kg+2.3kg * each inch over over 5 feet
For females: IBW=45.5kg+2.3kg * each inch over 5 feetPrescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
25
26. Example: Creatinine Clearance vs.
Age in a 5’5”, 55 kg Woman
301.190
411.170
531.150
651.130
CrClScrAge
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
26
27. Limitations in Estimating CrCl
Not all persons experience significant age-related
decline in renal function
Some patient’s muscle mass is reduced beyond that of
normal aging
Suggest using 1 mg/dL if serum creatinine is less than normal
(<0.7 mg/dL)
Not precise, may underestimate actual CrCl
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
27
28. Pharmacodynamics (PD)
Definition: the time course and intensity of
pharmacologic effect of a drug
Age-related changes:
sensitivity to sedation and psychomotor
impairment with benzodiazepines
level and duration of pain relief with narcotic
agents
drowsiness and lateral sway with alcohol
HR response to beta-blockers
sensitivity to anti-cholinergic agents
cardiac sensitivity to digoxinPrescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
28
29. Pharmacodynamics and Aging
Some effects are increased
alcohol increases drowsiness and lateral
sway
e.g. diazepam, morphine, theophylline
Some effects are decreased
diminished HR response to -blockers
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
29
30. PK and PD Summary
PK and PD changes generally result in decreased
clearance and increased sensitivity to medications
in older adults
Use of lower doses, longer intervals, slower titration
are helpful in decreasing the risk of drug
intolerance and toxicity
Careful monitoring is necessary to ensure successful
outcomes
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
30
31. Risk Factors for Drug Related
Problems in the Elderly
Suboptimal prescribing
Medication Errors
Medication nonadherence
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
31
32. Optimal Pharmacotherapy
Balance between overprescribing and
underprescribing
Correct drug
Correct dose
Targets appropriate condition
Is appropriate for the patient
Avoid “a pill for every ill”
Always consider non-pharmacologic therapy
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
32
33. Medication Appropriateness Index
1. Is there an indication?
2. Is the medication effective for the condition?
3. Is the dosage correct?
4. Are the directions correct?
5. Are the directions practical?
6. Are there clinically significant drug-drug interactions?
7. Are there clinically significant drug-disease
interactions?
8. Is there unnecessary duplication?
9. Is the duration of therapy acceptable?
10. Is this drug the least expensive alternative?Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
33
34. Additional Criteria for Drug Use
Compatible safety and side effect profile
Low risk of drug/nutrient interactions
T1/2 < 24h with no active metabolites
No adjustments for renal/hepatic function
Strength/dosage form match recommendations for older adults
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
34
35. Newer Drugs
What is unique about the new drug?
Is clinical data available?
How does it compare with traditional therapy?
Cost?
Coverage by third party payers?
Does potential advantage justify risk of new drug?
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
35
36. How to Prescribe Appropriately
1. Obtain complete drug history
2. Avoid prescribing prior to diagnosis
3. Review medications regularly
4. Know actions, adverse effects, toxicity
5. Start at low dose and titrate
6. Try not to start two drugs at the same time
7. Reach therapeutic dose before switching/adding
8. Consider non-pharmacological alternatives
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
36
37. 7. Educate patient/caregiver
8. Use one drug to treat two conditions
9. Keep regimen as simple as possible
10. Caution with combination products
11. Communicate with other prescribers
12. Avoid drugs from same class/similar actions
13. Avoid one drug to treat side effect of another
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
37
39. Consequences of Overprescribing
Adverse drug events (ADEs)
Drug interactions
Duplication of drug therapy
Decreased quality of life
Unnecessary cost
Medication non-adherence
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
39
40. Adverse Drug Events (ADEs)
Responsible for 5-28% of acute
geriatric hospital admissions
Greater than 95% of ADEs in the
elderly are considered
predictable and approximately
50% are considered preventable
Most errors occur at the ordering
and monitoring stages
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
40
41. Most Common Medications
Associated with ADEs in the Elderly
Opioid analgesics
NSAIDs
Anticholinergics
Benzodiazepines
Also: cardiovascular agents, CNS agents, and
musculoskeletal agents
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
41
42. The Beers Criteria
High Potential for
Severe ADE
High Potential for
Less Severe ADE
amitriptyline
chlorpropamide
digoxin >0.125mg/d
disopyramide
GI antispasmodics
meperidine
methyldopa
pentazocine
ticlopidine
antihistamines
diphenhydramine
dipyridamole
ergot mesyloids
indomethacin
muscle relaxants
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD 42
43. Patient Risk Factors for ADEs
Polypharmacy
Multiple co-morbid conditions
Prior adverse drug event
Low body weight or body mass
index
Age > 85 years
Estimated CrCl <50 mL/minPrescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
43
44. Prescribing Cascade
Drug 1
Adverse drug effect
misinterpreted as new
medical condition
Drug 2
Adverse Drug
Effect
Drug 3
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
44
45. Drug-Drug Interactions (DDIs)
May lead to adverse drug events
Likelihood as number of medications
Most common DDIs:
cardiovascular drugs
psychotropic drugs
Most common drug interaction effects:
confusion
cognitive impairment
hypotension
acute renal failure
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
45
46. Concepts in Drug-Drug Interactions
Absorption may be or
Drugs with similar effects can result additive
effects
Drugs with opposite effects can antagonize
each other
Drug metabolism may be inhibited or induced
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
46
48. Common Drug-Disease Interactions
Combination Risk
NSAIDs + CHF
Thiazolidinediones + CHF
Fluid retention; CHF exacerbation
BPH + anticholinergics Urinary retention
CCB + constipation
Narcotics + constipation
Anticholinergics + constipation
Exacerbation of constipation
Metformin + CHF Hypoxia; increased risk of lactic
acidosis
NSAIDs + gastropathy Increased ulcer and bleeding risk
NSAIDs + HTN Fluid retention; decreased
effectiveness of diuretics
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD 48
49. Drug-Disease Interactions
Obesity alters Vd of lipophilic drugs
Ascites alters Vd of hydrophilic drugs
Dementia may sensitivity, induce paradoxical
reactions to drugs with CNS or anticholinergic activity
Renal or hepatic impairment may impair metabolism
and excretions of drugs
Drugs may exacerbate a medical condition
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
49
50. Drug-Disease Interactions
Decongestants and anticholinergics → BPH
CCB’s and anticholinergics → constipation
NSAIDs → Heart Failure
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
50
51. Drug-Induced Osteoporosis
Identify the drug listed below that has been
associated with osteoporosis in elderly adults.
a.Alprazolam
b.Divalproex
c.Fluoxetine
d.Risperidone
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
51
52. Drug-Induced Osteoporosis
Identify the drug listed below that has been
associated with osteoporosis in elderly adults.
a.Alprazolam
b.Divalproex
c.Fluoxetine
d.Risperidone
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
52
54. GENERAL PRINCIPLES
1. Start with a low dose, & titrate the medication
dose slowly.
2. Half life of many drugs are prolonged due to
reduced hepatic and renal function.
3. Optimal therapeutic response is not obtained
with rapid dose escalation because steady
state conc. of the drug is not reached.
4. Fewest no: of drugs should be used to treat pts.
5. Always evaluate possible drug toxicity.
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
54
55. Prescribing Appropriately
Determine therapeutic endpoints and plan for assessment
Consider risk vs. benefit
Avoid prescribing to treat side effect of another drug
Use 1 medication to treat 2 conditions
Consider drug-drug and drug-disease interactions
Use simplest regimen possible
Adjust doses for renal and hepatic impairment
Avoid therapeutic duplication
Use least expensive alternative
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
55
56. Preventing Polypharmacy
Review medications regularly and each
time a new medication started or dose is
changed
Maintain accurate medication records
(include vitamins, OTCs, and herbals)
“Brown-bag”
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
56
57. Brown Bag
Rx, OTC, Herbal, Vitamins, Supplements
Ask what each medication for
Ask how it is taken
Discontinue unnecessary medications
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
57
58. OTC’s
Elderly take average of 2-4 OTC’s qd
Laxatives used in 1/3 to 1/2
NSAIDs, antihistamines, H2 blockers
ALL CAN CAUSE SIDE EFFECTS!
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
58
59. Medication Adherence is big
problem??
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
59
60. Factors Influencing Ability to
Comply
3 chronic conditions
> 5 prescription medications
12 medication dosages per day
Regimen changed 4 times in past 12 months
3 prescribers
Significant cognitive or physical impairment
Living alone in community
Recently discharged from hospital
Reliance on caregiver
Low literacy Medication cost
Demonstrated poor compliance history
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
60
61. Potential Barriers to
Improving Adherence
• Poor attitude
• Memory deficits
• Language
• Literacy
• Cultural beliefs
• Alternative health
beliefs
• Poor support
• Pride
• Denial
• Fear or
embarrassment
• Side effects
• Religious beliefs
• Unable to “see”
results of drug
therapy
• Lack of choices
• CostPrescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
61
62. Strategies to Ensure Adherence
Find out about patient/family expectations; explain why
some may not be met
Provide information on illness / consequences of non-
adherence
Use a behavioral contract
Increase motivation by enlisting patient/family in
decision-making process
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
62
63. Strategies to Ensure Adherence
Ask patient/family to repeat instructions
Keep directions / labels simple,use lay terms
Give clear instructions on drug regimen, preferably in
writing
Emphasize importance of adherence at each visit
Involve patient’s spouse or partner
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
63
64. Use Adherence Enhancing Aids
Medication record
Drug calendar
Medication boxes
Magnification for insulin syringes
Spacers for MDI’s
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
64
65. Summary
Successful pharmacotherapy means using
the correct drug at the correct dose for
the correct indication in an individual
patient
Age alters PK and PD
ADEs are common among the elderly
Risk of ADEs can be minimized by
appropriate prescribing
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
65
67. Patient A is 82 years of age with a history of congestive heart
failure, glaucoma, hypertension, and osteoarthritis. Her
current medications are furosemide, potassium, lisinopril,
metoprolol, aspirin, timolol maleate opthamic solution
(Timoptic), acetaminophen (as needed), multivitamin,
and a calcium/vitamin D supplement (800 IU daily). She
has an appointment with a new orthopedic physician.
During the appointment, the patient complains of
persistent arthritic pain in her knee. The physician
prescribes the NSAID meloxicam (7.5 mg per day) for pain
and inflammation.
Case 1:
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
67
68. Case 1: Comments and Discussion
From the orthopedic standpoint, prescription of meloxicam is good
practice, as it should help to ameliorate patient A's symptoms.
However, from a cardiac standpoint, this is a risky approach due to
the potential side effect of fluid retention and its effect on the heart. In
general, NSAIDs can be dangerous for an individual of Patient A's age.
NSAIDs (including meloxicam, but also over-the-counter options like
ibuprofen) have been issued "black box" warnings by the U.S. Food
and Drug Administration for the increased risk of:
Serious and potentially fatal cardiovascular and thrombotic events,
including myocardial infarction and stroke
Serious adverse gastrointestinal events such as bleeding, ulcer, and
intestinal perforation (higher in elderly patients)
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
68
69. Patient A has a good working relationship with her primary care
provider, who has instructed her to contact him regarding any
changes in her medication regimen. She calls her physician prior to
taking the medication, and he advises her not to take the NSAID.
Instead, he devises a pain management plan that minimizes the
potential risks. Previously, Patient A was taking acetaminophen as
needed, averaging up to one dose daily. This is increased to twice
daily extended-release acetaminophen (650 mg). For breakthrough
pain, tramadol 25 mg every four hours (as needed) is prescribed.
Another option considered was the topical anti-inflammatory
diclofenac sodium 1% topical gel, which would have fewer side
effects than systemic agents. Aside from pharmacotherapy, the
patient is scheduled with a physical therapist to create a safe exercise
plan, including strengthening and range-of-motion exercises.
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
69
70. Case 2:
Patient B is a man, 78 years of age, who resides in a nursing facility. One
year ago, he fell and fractured his left hip and underwent surgical repair.
He returned to the nursing facility, completed rehabilitation, and
regained most of his prior function. After the surgery, Patient B was
prescribed warfarin to prevent deep vein thrombosis (DVT) after surgery.
During a routine survey, a state surveyor discovers that Patient B is still
being administered warfarin. After further investigation, it is discovered
that the warfarin was never discontinued after the appropriate duration
after the hip fracture repair. The surveyor considers warfarin an
unnecessary drug, and a citation (F-Tag 329) is issued. After contacting
the attending physician, the warfarin is promptly discontinued.
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
70
71. Case 2: Comments and Discussion
Patient B's case is an example of using the right drug but not using it for the correct
duration. After orthopedic surgery, warfarin is usually indicated for approximately two
to three months or until activity/ambulation has increased to a point that the risk of DVT
is reduced. There is a substantial burden of treatment with warfarin, including weekly
evaluations of prothrombin time/international normalized ratio (PT/INR), adverse
reactions, interactions, and increased risk of bleeding and brain hemorrhage,
especially for patients with a history of falls.
There is shared responsibility for this error between the prescriber/healthcare provider
and the facility. The provider did not follow through and discontinue the medication
when it was no longer needed, and the facility nursing staff should have realized that
the drug was no longer necessary and approached the provider for an order to
discontinue. The nursing facility could have called the orthopedic physician for orders
and duration of warfarin treatment after surgery. When a medication is started, the
stop date for that medication should be considered and established. The consultant
pharmacist could have intervened as well.
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
71
72. All ill don’t have pill…!!
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
72
73. References
Clin Geriatr Med 1998;14:681
J Gerontol 1998;(53A9A):M59
JAMA 2003;289:1107
Arch Intern Med 2003;163:2716-2724
Haynes RB, et al. Patient Education and Counseling; 1987;10:155-166
Better prescribing in the elderly; CGS Journal of CME; volume 2, issue 3,
2012
Prescribing for older people; James C Milton, Ian Hill-Smith and Stephen H
D Jackson; BMJ 2008;336;606-609
Doucet J, Chassagne P, Trivalle C, et al. Drug-drug interactions
related to hospital admissions in older adults: a prospective study of
1000 patients. J Am Geriatr Soc 1996;44(9):944-948.Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
73
74. Don’t forget:
If no Accident ;
Every one will
become a Geriatric
We don’t need your “Money” or
“Property”….
What we need is “Love”, “Care” &
“Affection”….!!
Prescribing Guidelines for Geriatrics: Dr. Asish Kumar Saha, PharmD
74